We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-4.46%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$10.5B
AUM Growth
+$4.68B
Cap. Flow
+$4.98B
Cap. Flow %
47.59%
Top 10 Hldgs %
29.39%
Holding
7,240
New
774
Increased
2,863
Reduced
2,421
Closed
823

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$413M
2
MSFT icon
Microsoft
MSFT
+$342M
3
AMZN icon
Amazon
AMZN
+$210M
4
TSLA icon
Tesla
TSLA
+$130M
5
NVDA icon
NVIDIA
NVDA
+$126M

Sector Composition

Rank Sector Weight
1 Technology 30.51%
2 Consumer Discretionary 11.81%
3 Healthcare 9.9%
4 Communication Services 9.49%
5 Financials 9.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TNYA icon
4101
Tenaya Therapeutics
TNYA
$163M
$12K ﹤0.01%
988
-1,156
-54% -$14K
UP icon
4102
Wheels Up
UP
$182M
$12K ﹤0.01%
20
-8
-29% -$5.77K
VIGL
4103
DELISTED
Vigil Neuroscience
VIGL
$12K ﹤0.01%
+1,773
New +$23.4K
VMD icon
4104
Viemed Healthcare
VMD
$350M
$12K ﹤0.01%
2,468
-17,398
-88% -$80.8K
WFCF icon
4105
Where Food Comes From
WFCF
$61.5M
$12K ﹤0.01%
1,100
+751
+215% +$9.67K
WNC icon
4106
Wabash National
WNC
$512M
$12K ﹤0.01%
822
-12,516
-94% -$221K
XMTR icon
4107
Xometry
XMTR
$5.52B
$12K ﹤0.01%
336
+69
+26% +$3.15K
DWTX
4108
Dogwood Therapeutics
DWTX
$72.3M
$12K ﹤0.01%
105
+104
+10,400% +$15.1K
WSO.B
4109
Watsco Inc Class B
WSO.B
$12K ﹤0.01%
40
-47
-54% -$13.7K
ENFN
4110
DELISTED
Enfusion, Inc.
ENFN
$12K ﹤0.01%
972
+464
+91% +$7.09K
GHSI
4111
DELISTED
Guardion Health Sciences, Inc. Common Stock
GHSI
$12K ﹤0.01%
1,048
+1,041
+14,871% +$21.1K
GBNY
4112
DELISTED
Generations Bancorp NY, Inc. Common Stock
GBNY
$12K ﹤0.01%
1,050
+672
+178% +$7.89K
GMFI
4113
DELISTED
Aetherium Acquisition Corp
GMFI
$12K ﹤0.01%
+1,170
New +$11.5K
HCMAU
4114
DELISTED
HCM Acquisition Corp Unit
HCMAU
$12K ﹤0.01%
+1,207
New +$12.1K
ORTX
4115
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$12K ﹤0.01%
1,692
-2,269
-57% -$22.2K
SRT
4116
DELISTED
Startek Inc.
SRT
$12K ﹤0.01%
2,814
+809
+40% +$3.82K
AVTA
4117
DELISTED
Avantax, Inc. Common Stock
AVTA
$12K ﹤0.01%
620
-1,678
-73% -$30.4K
GTH
4118
DELISTED
Genetron Holdings Limited ADS
GTH
$12K ﹤0.01%
1,872
+1,461
+355% +$16K
FATH
4119
DELISTED
Fathom Digital Manufacturing Corporation
FATH
$12K ﹤0.01%
94
-118
-56% -$19.2K
DMS
4120
DELISTED
Digital Media Solutions, Inc.
DMS
$12K ﹤0.01%
225
+41
+22% +$2.47K
NOVN
4121
DELISTED
Novan, Inc. Common Stock
NOVN
$12K ﹤0.01%
3,026
+544
+22% +$2K
ONCR
4122
DELISTED
Oncorus, Inc.
ONCR
$12K ﹤0.01%
6,798
-5,136
-43% -$14.4K
ATNX
4123
DELISTED
Athenex, Inc. Common Stock
ATNX
$12K ﹤0.01%
722
-307
-30% -$6.01K
BNFT
4124
DELISTED
Benefitfocus, Inc.
BNFT
$12K ﹤0.01%
990
-7,866
-89% -$83.9K
MDH
4125
DELISTED
MDH Acquisition Corp.
MDH
$12K ﹤0.01%
1,165
-224
-16% -$2.19K

Similar funds

Tower Research Capital (TRC)'s Q1 2022 Portfolio in Review

As of Q1 2022, Tower Research Capital (TRC) held 7,240 positions worth $10.5B, up 81% from $5.78B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Tower Research Capital (TRC) deployed $4.98B of net new capital in Q1 2022, opening 774 new positions and adding to 2,863 existing holdings. Its largest new stake was iShares MSCI USA Value Factor ETF: 132,204 shares worth $13.8M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $45.1M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2022 buy was iShares MSCI USA Value Factor ETF: 132,204 shares worth $13.8M.
  • Tower Research Capital (TRC) added most to Apple in Q1 2022, an estimated $413M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2022 reduction was iShares Russell 2000 ETF, cutting an estimated $45.1M.
  • Tower Research Capital (TRC) fully exited State Street Technology Select Sector SPDR ETF in Q1 2022, selling an estimated $51.9M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 29% of its $10.5B portfolio in Q1 2022.
  • Tower Research Capital (TRC) opened 774 new positions and closed 823 in Q1 2022.
  • Tower Research Capital (TRC)'s portfolio value rose 81% quarter-over-quarter to $10.5B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2022, filed 12 May 2022.